NCT00552669View on ClinicalTrials.gov

Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents

PHASE4CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions

Coronary Heart DiseaseCoronary Restenosis

Interventions

DRUG

Oral sirolimus

Oral sirolimus given orally during 14 days plus bare metal stent implantation was compared with DES.Oral sirolimus was given as bolus of 10 mg started day before intervention followed by 3mg per day during 13 days after PCI. 180 mg of Diltiazem was added during oral administration of sirolimus .

DEVICE

Drug Eluting stent

Any Drug eluting stent

Trial Locations (3)

1115

Sanatorio Otamendi y Miroli, Buenos Aires

1354

Sanatorio Las Lomas, San Isidro

1846

Clinica IMA, Adrogué

All Listed Sponsors

lead

Centro de estudios en Cardiologia Intervencionista

OTHER

NCT00552669 - Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents | Biotech Hunter | Biotech Hunter